Literature DB >> 26191286

Expression of p27 and PTEN and clinical characteristics in early laryngeal squamous cell carcinoma and their correlation with recurrence.

Jun-Quan Yang1, Zhen Liang2, Meng Wu3, Yu-Man Sun3, Hong-Xia Liu3.   

Abstract

Laryngeal squamous cell carcinoma is a common malignant tumor of otolaryngeal region. At present, effective treatment of laryngeal squamous cell carcinoma still depends on surgery and radiotherapy. In recent years, application of CO2 laser resection in the treatment of stage T1 glottic carcinoma can remove the tumor completely and reduce the injury of laryngeal tissues. But recurrence still happened in some postoperative patients. Here, we selected 131 patients to compare the therapeutic effects of CO2 laser resection and traditional split laryngeal surgery on the early laryngeal cancer, examined the expression of p27 and PTEN by immunohistochemistry in early laryngeal squamous cell carcinoma tissues in correlation to clinical outcome. After two years follow-up 14/85 (16.5%) of CO2 laser treatment group presented with local recurrence (recurrent group), while that of split laryngeal surgery group was 6/46 (13.0%). There was no statistical significance in recurrence rate between the two groups (P>0.05). 10 of all the 111 (9.0%) non-recurrent patients did not follow the doctor's advice to quit smoking after the operation, while 12 in the 20 (60.0%) recurrent patients did not; the difference between the two groups was statistically significant (P<0.01). The positive rates of p27 were 80.2% (105/131) and 43.5% (57/131), and that of PTEN were 83.2% (109/131) and 48.9% (64/131) in the cancer adjacent tissues (negative surgical margin tissues) and in laryngeal carcinoma tissues, respectively (P<0.001). The expression rates of p27 and PTEN in laryngeal carcinoma tissues of the recurrent group were 20.0% (4/20), 10.0% (2/20) and that in non recurrent group were 47.7% (53/111) and 55.9% (62/111), respectively, with a significant difference (P<0.001). In addition, the expression of p27 and PTEN in tumor resected marginal tissues of the recurrence group was 50.0% (10/20), 40.0% (8/20) and that in non recurrence group was 85.6% (95/111) and 91.0% (101/111), respectively; the difference was also statistically significant between both groups (P<0.001). In conclusion, there is no statistically significant difference in tumor recurrence rate between CO2 laser surgery and traditional split laryngeal surgery. Postoperative recurrence is closely related to resume smoking. The recurrence rate of p27 and/or PTEN-negative patients was higher than that of the positive ones,that should be followed up closely after treatment.

Entities:  

Keywords:  CO2 laser resection; Laryngeal squamous cell carcinoma; PTEN; p27; recurrence

Mesh:

Substances:

Year:  2015        PMID: 26191286      PMCID: PMC4503157     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  24 in total

Review 1.  [Local recurrence of CO2 laser surgery for patients with early glottic carcinoma: a systematic review and meta-analysis].

Authors:  Ying Wang; Jiaqing Zhou
Journal:  Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi       Date:  2012-09

2.  PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway.

Authors:  H Sun; R Lesche; D M Li; J Liliental; H Zhang; J Gao; N Gavrilova; B Mueller; X Liu; H Wu
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

3.  Transoral CO2 laser microsurgery for Tis-T3 supraglottic squamous cell carcinomas.

Authors:  Giorgio Peretti; Cesare Piazza; Mohssen Ansarin; Luigi De Benedetto; Daniela Cocco; Augusto Cattaneo; Piero Nicolai; Fausto Chiesa
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-05-25       Impact factor: 2.503

Review 4.  Potential prognostic and therapeutic role for angiogenesis markers in laryngeal carcinoma.

Authors:  Marco Lionello; Alberto Staffieri; Gino Marioni
Journal:  Acta Otolaryngol       Date:  2012-04-12       Impact factor: 1.494

5.  Surgical treatment of T1b glottic tumor, 10-years follow-up.

Authors:  D Marcotullio; M de Vincentiis; G Iannella; C Bigelli; G Magliulo
Journal:  Eur Rev Med Pharmacol Sci       Date:  2014       Impact factor: 3.507

6.  p21, p53, and p27 Kip1 alterations in benign and malignant tumors of sinonasal epithelium.

Authors:  Nesil Keleş; Burak Erdamar; Ahmet Kaur; Kemal Değer
Journal:  Otolaryngol Head Neck Surg       Date:  2003-07       Impact factor: 3.497

Review 7.  Prognostic relevance of cell proliferation in head and neck tumors.

Authors:  A Pich; L Chiusa; R Navone
Journal:  Ann Oncol       Date:  2004-09       Impact factor: 32.976

8.  Significance of anterior commissure involvement in early glottic squamous cell carcinoma treated with trans-oral CO2 laser microsurgery.

Authors:  Arsheed H Hakeem; Jagadish Tubachi; Sultan A Pradhan
Journal:  Laryngoscope       Date:  2013-04-18       Impact factor: 3.325

9.  Voice quality after treatment of early vocal cord cancer: a randomized trial comparing laser surgery with radiation therapy.

Authors:  Leena-Maija Aaltonen; Noora Rautiainen; Jaana Sellman; Kauko Saarilahti; Antti Mäkitie; Heikki Rihkanen; Jussi Laranne; Leenamaija Kleemola; Tuija Wigren; Eeva Sala; Paula Lindholm; Reidar Grenman; Heikki Joensuu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-10-01       Impact factor: 7.038

10.  The emerging role of the molecular marker p27 in the differential diagnosis of adrenocortical tumors.

Authors:  Sofia S Pereira; Tiago Morais; Madalena M Costa; Mariana P Monteiro; Duarte Pignatelli
Journal:  Endocr Connect       Date:  2013-08-28       Impact factor: 3.335

View more
  3 in total

1.  PTEN Is Associated With Worse Local Control in Early Stage Supraglottic Laryngeal Cancer Treated With Radiotherapy.

Authors:  Leonie Bruine de Bruin; Jan E Wachters; Michiel L Schrijvers; Lorian Slagter-Menkema; Mirjam F Mastik; Johannes A Langendijk; Jacqueline E van der Wal; Ed Schuuring; Bernard F A M van der Laan
Journal:  Laryngoscope Investig Otolaryngol       Date:  2019-06-12

2.  Signature microRNAs and long noncoding RNAs in laryngeal cancer recurrence identified using a competing endogenous RNA network.

Authors:  Zhengyi Tang; Ganguan Wei; Longcheng Zhang; Zhiwen Xu
Journal:  Mol Med Rep       Date:  2019-04-10       Impact factor: 2.952

3.  Lung cancer‑associated transcript 1 facilitates tumorigenesis in laryngeal squamous cell carcinoma through the targeted inhibition of miR‑493.

Authors:  Zhen Zhao; Yan Xing; Yan Liu; Shanghua Jing
Journal:  Mol Med Rep       Date:  2020-11-20       Impact factor: 2.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.